Diabetes Type 2 Clinical Trial
Official title:
Project Dulce for Filipino-Americans With Type 2 Diabetes
This study aims to culturally adapt an existing American Diabetes Association (ADA)-recognized diabetes self-management and support or DSMES (Diabetes Self Management Education Support) program (Project Dulce) and integrate an evidence-based text messaging program (Dulce Digital) for implementation in Filipino Americans (FAs) with type 2 diabetes mellitus (T2DM). Cultural adaptations aims to facilitate and enhance patient centered approaches and increase participant engagement by addressing barriers to DSMES unique to FAs, such as linguistic challenges, health literacy and numeracy, cultural beliefs and values, and technology access and use. In addition, this study aims to examine the effectiveness of the culturally and digitally adapted Project Dulce + Dulce Digital in improving diabetes knowledge, belief, attitudes, hemoglobin A1C (glycosylated hemoglobin), and self-management behaviors at baseline to 3 months and 6 months. The unprecedented increase of T2DM prevalence among racial and ethnic minority populations including FAs in recent decades demands for effective strategies to meet the needs in DSMES in this population. The outcomes of the current study will demonstrate that the culturally adapted Project Dulce and integration of Dulce Digital is effective in addressing the needs FAs, an underserved racial and ethnic minority group in high need of culturally appropriate DSMES.
Status | Recruiting |
Enrollment | 48 |
Est. completion date | June 30, 2025 |
Est. primary completion date | June 30, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Self-identified Filipino - Diagnosed with T2DM - Registered in the community clinic (or willing to register) - HbA1c =8% within 1 month of screening - Able to speak, read, write, and comprehend in English and Tagalog Exclusion Criteria: - Severe illness precluding frequent visits to clinic - Liver function tests (ALT and AST) > 3 times the upper limit of normal - Body mass index = 23 kg/cm - History of malignancy, except subjects who have been disease-free for >years, or whose only malignancy has been basal or squamous cell skin carcinoma - Creatinine >3.5 - History of drug or alcohol abuse within 12 months prior to enrollment - Not a permanent resident in the area - Current enrollee in Project Dulce - Blood donation of one pint or more within the past 30 days, or plasma donation within 7 days prior to screening - Anemia - Primary language other than English or Tagalog - Not willing to carry a mobile phone - Type 1 or gestational diabetes - Pregnant |
Country | Name | City | State |
---|---|---|---|
United States | Scripps Diabetes Center | Chula Vista | California |
United States | San Ysidro Health | National City | California |
United States | Scripps Whittier Diabetes Institute | San Diego | California |
Lead Sponsor | Collaborator |
---|---|
Scripps Whittier Diabetes Institute | National Center for Advancing Translational Sciences (NCATS) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Recruitment and Retention | Recruitment rate is the number of participants recruited divided by the maximum number of sites (n=1), divided by the number of months recruiting.
Retention rate is the number of participants who remained in the study at the last wave of data collection (6 months) as the proportion of the number of participants enrolled at the baseline assessment. |
6 months | |
Other | Participant Satisfaction | Study-adapted focus group questionnaire evaluates participant experiences and satisfaction related to specific aspects of the peer-led diabetes education program (e.g., curriculum, handouts and PowerPoint Slides, peer educator) and text messaging component (e.g., content of text messages, receiving and responding to text messages, follow-up phone calls from the peer educator). | 6 months | |
Primary | Change from Baseline Diabetes Knowledge at 3 months | Diabetes Knowledge Test (Fitzgerald, Funnell, Anderson, et al., 2016) is a 23-item measure of diabetes knowledge, with general questions related to symptoms, self-management (e.g., diet, exercise, foot care, blood glucose monitoring, insulin) , and complications (e.g., low and high blood sugar). Greater scores indicate greater diabetes knowledge. | 3 months | |
Primary | Change from Baseline Diabetes Knowledge at 6 months | Diabetes Knowledge Test (Fitzgerald, Funnell, Anderson, et al., 2016) is a 23-item measure of diabetes knowledge, with general questions related to symptoms, self-management (e.g., diet, exercise, foot care, blood glucose monitoring, insulin) , and complications (e.g., low and high blood sugar). Greater scores indicate greater diabetes knowledge. | 6 months | |
Primary | Change from Baseline Health Belief Model Scale at 3 months | Health Belief Model scale (Tan, 2004) is comprised of 36 items that evaluate the health beliefs and attitudes about complication prevention behaviors and active health related behaviors on individuals with diabetes. Responses are on a 5-point Likert-type scale (1=strongly disagree, 5=strongly agree), with lower scores indicating greater negative beliefs. | 3 months | |
Primary | Change from Baseline Health Belief Model Scale at 6 months | Health Belief Model scale (Tan, 2004) is comprised of 36 items that evaluate the health beliefs and attitudes about complication prevention behaviors and active health related behaviors on individuals with diabetes. Responses are on a 5-point Likert-type scale (1=strongly disagree, 5=strongly agree), with lower scores indicating greater negative beliefs. | 6 months | |
Primary | Change in Baseline Self-Efficacy for Diabetes Scale at 3 months | Stanford Self-Efficacy for Diabetes Scale (Lorig, Stewart, Ritter, et al., 1996) is comprised of 8 items that measure the confidence of a participant in performing self-care activities such as eating meals every 4 to 5 hours, following a healthful diet, exercising, and blood glucose monitoring. Response options range from 1=not at all confident to 10=totally confident, with higher scores indicating greater self-efficacy. | 3 months | |
Primary | Change in Baseline Self-Efficacy for Diabetes Scale at 6 months | Stanford Self-Efficacy for Diabetes Scale (Lorig, Stewart, Ritter, et al., 1996) is comprised of 8 items that measure the confidence of a participant in performing self-care activities such as eating meals every 4 to 5 hours, following a healthful diet, exercising, and blood glucose monitoring. Response options range from 1=not at all confident to 10=totally confident, with higher scores indicating greater self-efficacy. | 6 months | |
Secondary | Change in Baseline Summary of Diabetes Self-Care Activities at 3 months | Summary of Diabetes Self-Care Activities measure (Toobert, Hampson, & Glassgow, 2000) is a 13-item brief questionnaire that assesses respondents adherence to self-management behavior recommendations in the past 7 days, including general and specific diet, exercise, blood glucose testing, foot care, medication adherence, and smoking, with greater scores indicating greater adherence. | 3 months | |
Secondary | Change in Baseline Summary of Diabetes Self-Care Activities at 6 months | Summary of Diabetes Self-Care Activities measure (Toobert, Hampson, & Glassgow, 2000) is a 13-item brief questionnaire that assesses respondents adherence to self-management behavior recommendations in the past 7 days, including general and specific diet, exercise, blood glucose testing, foot care, medication adherence, and smoking, with greater scores indicating greater adherence. | 6 months | |
Secondary | Change in Baseline Block Food Frequency Questionnaire at 3 months | Block Food Frequency Questionnaire (Block et al., 1995) measures frequency of fruit, vegetable and fiber consumption, and fat (and saturated fat) consumption each week using seven frequency categories ranging from less than once a week to 2 or more a day. Minor modifications were included to add food items commonly consumed in a Filipino diet (e.g., "Any other vegetables such as corn broccoli, zucchini, or vegetables commonly used Filipino cooking such as sitaw, kalabasa, sayote, upo, monggo, malunggay, amapalaya, pechay, kangkong, okra, etc.) | 3 months | |
Secondary | Change in Baseline Block Food Frequency Questionnaire at 6 months | Block Food Frequency Questionnaire (Block et al., 1995) measures frequency of fruit, vegetable and fiber consumption, and fat (and saturated fat) consumption each week using seven frequency categories ranging from less than once a week to 2 or more a day. Minor modifications were included to add food items commonly consumed in a Filipino diet (e.g., "Any other vegetables such as corn broccoli, zucchini, or vegetables commonly used Filipino cooking such as sitaw, kalabasa, sayote, upo, monggo, malunggay, amapalaya, pechay, kangkong, okra, etc.) | 6 months | |
Secondary | Change in Baseline International Physical Activity Questionnaire-Short Form at 3 months | International Physical Activity -Short Form (Craig et al., 2003) assesses the amount of physical activity (work, leisure, and other) and sedentary time in the past 7 days. | 3 months | |
Secondary | Change in Baseline International Physical Activity Questionnaire-Short Form at 6 months | International Physical Activity -Short Form (Craig et al., 2003) assesses the amount of physical activity (work, leisure, and other) and sedentary time in the past 7 days. | 6 months | |
Secondary | Change in Baseline Glycosylated Hemoglobin A1C (HbA1c) at 3 months; % Units | HbA1c is measure of blood sugar level and assessed using blood samples following a 12-hour fast. Samples will be processed by Quest Diagnostics Inc and assayed by Immunoturbidimetry (Integra 800, Roche). | 3 months | |
Secondary | Change in Baseline Glycosylated Hemoglobin A1C (HbA1c) at 6 months; % Units | HbA1c is measure of blood sugar level and assessed using blood samples following a 12-hour fast. Samples will be processed by Quest Diagnostics Inc and assayed by Immunoturbidimetry (Integra 800, Roche). | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
Active, not recruiting |
NCT04954313 -
Baseline Oral Health Study: UnCoVer the Connections to General Health
|
Phase 4 | |
Not yet recruiting |
NCT06437782 -
Exploration of Health Literacy in Diabetes in Reunion Island and France
|
||
Completed |
NCT01354925 -
Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan
|
Phase 4 | |
Completed |
NCT01206725 -
Exercise Study on Cardiac Function in Patients With Diabetes Mellitus Type 2 and Diastolic Dysfunction
|
N/A | |
Completed |
NCT00997282 -
A Study of OPC-262 in Patients With Type 2 Diabetes
|
Phase 2/Phase 3 | |
Completed |
NCT00637546 -
Gait and Balance of Diabetes Type 2 Patients
|
Phase 2/Phase 3 | |
Completed |
NCT00464880 -
Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy
|
Phase 1/Phase 2 | |
Withdrawn |
NCT02057497 -
An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms
|
N/A | |
Active, not recruiting |
NCT05014204 -
Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes
|
N/A | |
Recruiting |
NCT03662217 -
Personalized Nutrition for Diabetes Type 2
|
N/A | |
Completed |
NCT04276051 -
Cryovagotomy Diabetes Trial
|
N/A | |
Completed |
NCT02569684 -
Effects of Prebiotics on GLP-1 in Type 2 Diabetes
|
N/A | |
Active, not recruiting |
NCT01933529 -
ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)
|
Phase 2 | |
Terminated |
NCT01722474 -
Assessment of Three Instruments for the Non-invasive Measurement of Arterial Stiffness.
|
N/A | |
Completed |
NCT00977262 -
Postprandial Inflammation and Fatty Acids
|
N/A | |
Completed |
NCT00518427 -
Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine
|
Phase 4 | |
Recruiting |
NCT03834207 -
A Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacy
|
N/A | |
Active, not recruiting |
NCT05228067 -
Enhancing Brain Health by tDCS in Persons With Overweight and Obesity
|
N/A | |
Active, not recruiting |
NCT05689684 -
Arabinoxylan-oligosaccharides (AXOS) for the Management of Type-2 Diabetes
|
N/A |